CINNAGEN

Business Type: Manufacturer (Biopharmaceutical Company)

Company Overview:

CinnaGen is a leading biopharmaceutical company based in Iran, specializing in the research, development, and manufacturing of high-quality biosimilar medicines and recombinant proteins. Established in 1994, the company has grown into one of the largest biotechnology hubs in the Middle East.

Key Activities:

1. Manufacturing: CinnaGen operates advanced, state-of-the-art production facilities that comply with international Good Manufacturing Practice (GMP) standards.

2. R&D: The company invests heavily in research and development to produce affordable therapeutic solutions for complex diseases.

3. Product Portfolio: Their product range includes treatments for Multiple Sclerosis (MS), cancer, infertility, and various autoimmune disorders.

4. Export: Beyond the domestic market, CinnaGen exports its pharmaceutical products to numerous countries across the globe, maintaining a strong focus on quality control and international regulatory compliance.

Conclusion:

CinnaGen is a manufacturer. It owns and operates its own production plants and laboratories, focusing on the end-to-end process of developing and producing biopharmaceutical products rather than acting as a simple trading company.

CINNAGEN PRODUCT PORTFOLIO

Biological Products

CinnoVex (Interferon Beta-1a)

Used for the treatment of Relapsing-Remitting Multiple Sclerosis.

ReciGen (Interferon Beta-1a)

Used for the treatment of Multiple Sclerosis.

CinnoPar (Teriparatide)

Used for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture.

Follistim (Follitropin Beta)

Used for the treatment of infertility.

CinnoTropin (Somatropin)

Used for the treatment of growth hormone deficiency.

Gonal-f (Follitropin Alfa)

Used for the treatment of infertility.

PegaGen (Pegfilgrastim)

Used to decrease the incidence of infection in patients receiving myelosuppressive anti-cancer drugs.

CinnoPoietin (Epoetin Alfa)

Used for the treatment of anemia.

CinnoRA (Adalimumab)

Used for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriasis.

Zytiga (Abiraterone Acetate)

Used for the treatment of prostate cancer.

CinnoHercept (Trastuzumab)

Used for the treatment of HER2-positive breast cancer.

CinnoMab (Rituximab)

Used for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia.

CinnoVera (Bevacizumab)

Used for the treatment of various types of cancer including colorectal and lung cancer.

Diagnostic Kits

Cinnagen also produces a wide range of molecular biology diagnostic kits, including:

PCR Master Mix

DNA Extraction Kits

RNA Extraction Kits

Real-Time PCR Kits

Various Laboratory Reagents and Enzymes